Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
MAGL-IN-4 | MAGL Inhibitor | MedChemExpress
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Molecules | Free Full-Text | Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition - RSC Advances (RSC Publishing)
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses | Molecular Psychiatry
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect
MAGL-IN-1 | MAGL Inhibitor | MedChemExpress
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
ASAP] Design and Synthesis of Novel Spiro Derivatives as Potent and
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis - Hernández‐Torres - 2014 - Angewandte Chemie International Edition - Wiley Online Library
Chemical structures of representative urea-based MAGL inhibitors 22e27... | Download Scientific Diagram
Structural modifications of MAGL inhibitor 144. | Download Scientific Diagram
Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive Group that Is Bioisosteric with Endocannabinoid Substrates - ScienceDirect
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Representative MAGL inhibitors along with their IC 50 value. | Download Scientific Diagram
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis: Cell
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
MAGL Inhibitor III, JZL184 - CAS 1101854-58-3 - Calbiochem | 475741
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants | Bentham Science
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect